How do I differentiate between Stable Angina (SA), Unstable Angina (UA), ST-Elevation Myocardial Infarction (STEMI), and Non-ST-Elevation Myocardial Infarction (NSTEMI) based on onset, symptoms, and pathogenesis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Differentiation Between Stable Angina, Unstable Angina, STEMI, and NSTEMI

The key differences between Stable Angina, Unstable Angina, STEMI, and NSTEMI lie in their onset patterns, symptom presentation, and underlying pathophysiological mechanisms, with STEMI representing the most severe form requiring immediate reperfusion therapy.

Pathogenesis

Stable Angina

  • Mechanism: Fixed atherosclerotic narrowing of coronary arteries causing predictable ischemia with exertion
  • Pathology: Stable plaque with >70% stenosis causing supply-demand mismatch only during increased demand
  • No plaque disruption or acute thrombosis

Unstable Angina (UA)

  • Mechanism: Disruption or erosion of atherosclerotic plaque with partial/transient thrombosis 1
  • Pathology: Subtotally occlusive thrombus on pre-existing plaque or dynamic obstruction (coronary spasm) 1
  • No myocardial necrosis: Biomarkers remain normal despite ischemia 2

NSTEMI

  • Mechanism: Plaque rupture with subtotal occlusion or distal embolization 1
  • Pathology: Partial/subtotal coronary occlusion with sufficient ischemia to cause myocardial necrosis 2
  • Myocardial damage: Detectable cardiac biomarkers (troponin) indicating cell death 1

STEMI

  • Mechanism: Complete thrombotic occlusion of a coronary artery 2
  • Pathology: Total occlusion with minimal/no collateral circulation 2
  • Extensive myocardial damage: Transmural infarction with ST-segment elevation on ECG 2

Onset Pattern

Stable Angina

  • Predictable pattern: Occurs with specific level of exertion
  • Consistent threshold: Similar activities consistently trigger symptoms
  • Brief episodes: Typically resolves within 5 minutes with rest or nitroglycerin 1

Unstable Angina

  • New onset: Severe angina of recent onset (≤2 months)
  • Accelerating pattern: Previously diagnosed angina that has become more frequent, longer in duration, or occurs with less exertion
  • Rest angina: Angina occurring at rest or with minimal exertion, usually lasting >20 minutes 1

NSTEMI

  • Abrupt onset: Often occurs at rest or with minimal exertion
  • Prolonged symptoms: Typically >20 minutes, not fully relieved by rest or nitroglycerin
  • May have crescendo pattern: Worsening of previously stable symptoms 1

STEMI

  • Sudden, severe onset: Typically dramatic presentation
  • Persistent symptoms: Continuous chest pain not relieved by rest or nitroglycerin
  • Duration >30 minutes: Often unremitting without intervention 2

Symptoms

Stable Angina

  • Predictable chest discomfort: Deep, poorly localized chest or arm discomfort
  • Triggered by: Physical exertion, emotional stress, cold weather, heavy meals
  • Relief with rest: Symptoms resolve within 5 minutes of rest or nitroglycerin 1

Unstable Angina

  • Similar to stable angina but more severe and prolonged
  • May occur at rest: Not necessarily triggered by exertion
  • Crescendo pattern: Increasing frequency, intensity, or duration 1
  • No biomarker elevation: Distinguishes it from NSTEMI 2

NSTEMI

  • Similar presentation to unstable angina:
    • Central/substernal compression or crushing chest pain
    • Pressure, tightness, heaviness, burning sensation
    • Radiation to neck, jaw, shoulders, back, or arms 1
  • Associated symptoms: Dyspnea, diaphoresis, nausea/vomiting 1
  • Atypical presentations more common in:
    • Women
    • Elderly patients
    • Diabetic patients (may have silent ischemia) 1

STEMI

  • Intense, persistent chest pain: Often described as crushing or pressure-like
  • Widespread radiation: Often radiates to jaw, neck, arms, back
  • Associated symptoms: Prominent dyspnea, diaphoresis, nausea/vomiting, lightheadedness
  • Cardiogenic shock symptoms: May include hypotension, pulmonary edema in extensive infarcts 2

Diagnostic Findings

Stable Angina

  • ECG: Normal at rest or minor ST-T changes during pain
  • Biomarkers: Normal troponin levels
  • Stress testing: Positive for inducible ischemia

Unstable Angina

  • ECG: May show transient ST depression, T-wave inversion, or be normal 2
  • Biomarkers: Normal cardiac troponin (key distinguishing feature from NSTEMI) 1, 2
  • Coronary angiography: Often shows significant stenosis or plaque disruption

NSTEMI

  • ECG: ST depression, T-wave inversion, or may be normal initially 2
  • No persistent ST elevation: Key distinguishing feature from STEMI
  • Biomarkers: Elevated cardiac troponin (>99th percentile upper reference limit) 1
  • Angiography: Usually subtotal occlusion or multiple severe stenoses

STEMI

  • ECG: Persistent ST-segment elevation in anatomically contiguous leads 2
  • Biomarkers: Elevated cardiac troponin (may not be elevated initially)
  • Angiography: Complete occlusion of an epicardial coronary artery 2

Clinical Pearls and Pitfalls

Important Considerations

  1. Biomarkers are critical: The distinction between UA and NSTEMI is based solely on cardiac biomarkers (troponin) 1

  2. Atypical presentations are common in:

    • Women (more likely to present with atypical symptoms) 1
    • Elderly (may present with dyspnea, confusion, or fatigue) 1
    • Diabetics (may have silent ischemia due to autonomic neuropathy) 1
  3. Delayed presentations: Patients with NSTEMI without chest pain delay seeking care longer (average 7.9 vs 5.3 hours) and have higher mortality (23.3% vs 9.3%) 1

  4. Don't rely solely on ECG: Normal initial ECG doesn't exclude ACS; serial ECGs and biomarkers are essential 2

  5. Symptoms that are NOT characteristic of cardiac ischemia:

    • Pleuritic pain (sharp pain with breathing)
    • Pain localized to a fingertip
    • Pain reproduced by movement or palpation
    • Very brief episodes lasting seconds
    • Pain radiating to lower extremities 1

Risk Stratification

  • All patients with suspected ACS should have:

    • 12-lead ECG within 10 minutes of presentation
    • Initial and serial cardiac biomarkers (troponin)
    • Risk stratification using validated tools (TIMI, GRACE scores) 2
  • High-risk features warranting urgent intervention:

    • Recurrent/ongoing chest pain
    • Dynamic ECG changes
    • Elevated troponin
    • Hemodynamic instability
    • Ventricular arrhythmias 1

Summary Table

Feature Stable Angina Unstable Angina NSTEMI STEMI
Onset Predictable with exertion New onset, accelerating, or at rest Often sudden, at rest Sudden, severe
Duration <5 minutes >20 minutes >20 minutes >30 minutes
Relief Rest/NTG Partial/delayed with rest/NTG Limited relief with rest/NTG No relief without intervention
ECG Normal at rest May show ischemic changes ST depression/T-wave inversion ST-segment elevation
Biomarkers Normal Normal Elevated Elevated
Pathology Fixed stenosis Plaque disruption with partial/transient thrombosis Subtotal occlusion Complete occlusion
Myocardial Necrosis Absent Absent Present Present (transmural)

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Acute Coronary Syndromes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.